Literature DB >> 7946359

Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments.

B T Hope1, H E Nye, M B Kelz, D W Self, M J Iadarola, Y Nakabeppu, R S Duman, E J Nestler.   

Abstract

Following chronic cocaine treatment, we have found a long-lasting increase in AP-1 binding in the rat nucleus accumbens and striatum, two important targets of the behavioral effects of cocaine. This increase develops gradually over several days and remains at 50% of maximal levels 7 days after the last cocaine exposure. Supershift experiments, along with one- and two-dimensional Western blots, indicate that this chronic AP-1 complex contains at least four Fos-related antigens (FRAs), some of which display delta FosB-like immunoreactivity, that are induced selectively by chronic, but not acute, cocaine treatment. The same chronic FRAs were also induced by several different types of chronic treatments in a region-specific manner in the brain. Thus, the chronic FRAs and associated chronic AP-1 complex could mediate some of the long-term changes in gene expression unique to the chronic-treated state as opposed to the acute-treated and normal states.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946359     DOI: 10.1016/0896-6273(94)90061-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  170 in total

1.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

Review 2.  DeltaFosB: a sustained molecular switch for addiction.

Authors:  E J Nestler; M Barrot; D W Self
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

Review 4.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

5.  NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration.

Authors:  X Y Cha; R C Pierce; P W Kalivas; S A Mackler
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

6.  Repeated cocaine self-administration causes multiple changes in rat frontal cortex gene expression.

Authors:  Willard M Freeman; Karen Brebner; Kruti M Patel; Wendy J Lynch; David C S Roberts; Kent E Vrana
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

7.  Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons.

Authors:  M A Schwarzschild; R L Cole; S E Hyman
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

8.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

9.  Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia.

Authors:  Hiroko Nomaru; Kunihiko Sakumi; Atsuhisa Katogi; Yoshinori N Ohnishi; Kosuke Kajitani; Daisuke Tsuchimoto; Eric J Nestler; Yusaku Nakabeppu
Journal:  Glia       Date:  2014-04-25       Impact factor: 7.452

10.  Epigenetic change detection and pattern recognition via Bayesian hierarchical hidden Markov models.

Authors:  Xinlei Wang; Miao Zang; Guanghua Xiao
Journal:  Stat Med       Date:  2012-10-25       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.